LMAT Stock Analysis: Buy, Sell, or Hold?
LMAT - LeMaitre Vascular, Inc.
$84.97
1.11 (1.32%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When LMAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LMAT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: LMAT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$84.54
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$52.49
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LMAT is currently trading at $84.97, which is considered fair relative to its 30-day fair value range of $82.62 to $86.06. The stock's valuation (Forward PE: 32.4) is in line with its historical norms (32.5). Remarkably, the market is currently pricing in an annual earnings decline of 0.1% over the next few years. This pessimistic expectation contrasts with the company's recent 53.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, LMAT is in a downtrend. The price is currently testing key support at $83.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $103.67 (+23.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LMAT is in a downtrend. The price is currently testing key support at $83.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $103.67 (+23.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$82.62 -
$86.06
Company Quality Score
54/100
(HOLD)
Options IV Signal
2th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
77.7%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 2th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.6% below Wall St target ($103.67)
Fair Price Analysis
30-Day Fair Range
$82.62 -
$86.06
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$3.56
(4.2%)
Support & Resistance Levels
Support Level
$83.27
Resistance Level
$88.38
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
32.40
Wall Street Target
$103.67
(+23.6%)
Revenue Growth (YoY)
11.4%
Earnings Growth (YoY)
53.6%
Profit Margin
22.1%
Valuation Discount vs History
-0.1% cheaper
PE vs Historical
32.4 vs 32.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.1%
(market-implied from PE analysis)
1-Year Target
$83.78
(0%)
2-Year Target
$83.69
(0%)
3-Year Target
$83.61
(0%)
3-Yr Target (if PE normalizes)
(PE: 32→33)
$83.86
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.4, Growth: 7.0%)
$102.82
(+23%)
Base:
(SPY PE: 22.3, Growth: 7.0%)
$70.76
(-16%)
Bear:
(PE: 19.0, Growth: 7.0%)
$60.15
(-28%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (32x PE) as earnings recover.
Trailing PE: 36.66 | Current EPS (TTM): $2.32
Bull Case
$104.37
(+23%)
Analyst growth 11.6%, PE expands to 40.3
Base Case
$94.89
(+12%)
Market implied 11.6%, PE stable at 36.7
Bear Case
$57.84
(-32%)
Severe decline -20.0%, PE contracts to 31.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 32.4 to 32.5
Stabilization Target:
$84.11
(+0.3%)
PE Expansion Potential:
+0.3%
Last updated: January 31, 2026 11:06 AM ET
Data refreshes hourly during market hours. Next update: 12:06 PM
Data refreshes hourly during market hours. Next update: 12:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LMAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
David B Roberts
SELL
10815 shares
2025-08-11
John A Roush
SELL
6561 shares
2025-08-11
Bridget A Ross
SELL
2500 shares
2025-08-08
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced LMAT Option Strategies
Professional options setups generated by AI based on today's LMAT price and gamma walls.
